What Is Ginkgo Used for Today?
| What Is the Scientific Evidence for Ginkgo?
| Interactions You Should Know About
Traceable back 300 million years, the ginkgo is the oldest surviving species of tree. Although it died out in Europe during the Ice Age, ginkgo survived in China, Japan, and other parts of East Asia. It has been cultivated extensively for both ceremonial and medical purposes, and some particularly revered trees have been lovingly tended for more than 1,000 years.
In traditional Chinese herbology, tea made from ginkgo seeds has been used for numerous problems, most particularly asthma and other respiratory illnesses. The leaf was not used. But in the 1950s, German researchers started to investigate the medical possibilities of ginkgo leaf extracts rather than remedies using the seeds. Thus, modern ginkgo preparations are not the same as the traditional Chinese herb, and the comparisons often drawn are incorrect.
What Is Ginkgo Used for Today?
Fairly good evidence indicates that ginkgo is effective for
and other severe forms of memory and mental function decline; when used for this purpose, it appears to be as effective as standard drugs.
Inconsistent evidence hints that ginkgo might be helpful for
and mental function in seniors without severe memory loss as well.
Weak evidence hints that ginkgo (alone or in combination with
) may be helpful for enhancing memory or alertness in younger people.
(another substance used to enhance mental function) along with ginkgo might increase its efficacy.
In addition, ginkgo may be effective for the treatment of restricted circulation in the legs due to hardening of the arteries known as
One substantial, well-designed double-blind, placebo-controlled study found evidence that ginkgo extract taken at a dose of 480 mg or 240 mg daily may be helpful for
Weak and, in some cases inconsistent,
evidence from preliminary double-blind trials hints that ginkgo might be helpful for
69sudden hearing loss
Although study results conflict, on balance the evidence suggests that ginkgo is
(ringing in the ear).
Three small, double-blind trials enrolling a total of about 100 people found preliminary evidence that use of the herb
can help prevent
However, a large scale, double-blind study enrolling 614 people, failed to find benefit.
(The drug acetazolamide, however, did provide significant benefits compared to placebo.) A similarly designed smaller study enrolling 57 people also failed to find ginkgo effective.
Overall, the balance of evidence suggests that ginkgo is not effective for this purpose.
Numerous case reports and uncontrolled studies raised hopes that ginkgo might be an effective treatment for
sexual dysfunction in men
, particularly in those cases related to certain antidepressant medications.
However, the results of a number of double-blind studies (see
Why Does this Database Rely on Double-blind Studies?
) indicate that ginkgo is no more effective than placebo, whether or not subjects are taking antidepressants.
One small study failed to find ginkgo helpful for the treatment of
Two studies failed to find ginkgo helpful in
In addition, another study found ginkgo biloba did not improve cognitive function on neuropsychological test scores compared to placebo in a randomized trial of 121 patients with multiple sclerosis.
This was also supported in a review of 4 studies. However, ginkgo was associated with improving fatigue symptoms after 4 weeks when compared to placebo.
Chinese research suggests that ginkgo might enhance the effects of drugs used for
as well as
Antipsychotic drugs can cause a neurological condition called
, which involves troubling, uncontrollable body movements.
One randomized study found that ginkgo (240 mg/day for 12 weeks) was more helpful than placebo in reducing tardive dyskinesia symptoms in people with schizophrenia.
evaluated combination therapy with ginkgo extract and the chemotherapy drug 5FU for the treatment of pancreatic cancer, on the theory that ginkgo might enhance blood flow to the tumor and thereby help 5FU penetrate better.
The results were promising, but much better research must be performed before ginkgo can be recommended for this use.
Similarly inadequate evidence hints at benefits in dyslexia.
Ginkgo has also been proposed as a treatment for
, but there is little evidence that it is effective for these conditions.
There are some theoretical safety concerns regarding ginkgo and
for more information.
What Is the Scientific Evidence for Ginkgo?
Alzheimer’s Disease and Non-Alzheimer’s Dementia
In the past, European physicians believed that the cause of mental deterioration with age (senile dementia) was reduced circulation in the brain due to atherosclerosis. Since ginkgo is thought to improve circulation,
they assumed that ginkgo was simply getting more blood to brain cells and thereby making them work better.
However, the contemporary understanding of age-related memory loss and mental impairment no longer considers chronically restricted circulation the primary issue. Ginkgo (and other drugs used for dementia) may instead function by directly stimulating nerve-cell activity and protecting nerve cells from further injury,
although improvement in circulatory capacity may also play a role.
Numerous double-blind, placebo-controlled studies have found ginkgo extract effective for dementia; among these, studies rated as “high quality” by accepted scientific norms included a total of more than 2,000 people.
For example, one major US trial published in 1997 enrolled more than 300 people with Alzheimer’s disease or non-Alzheimer’s dementia.
Participants were given either 40 mg of
extract or placebo 3 times daily for a period of 52 weeks. The results showed significant but not entirely consistent improvements in the treated group.
Another study, published in 2007, followed 400 people for 22 weeks, and used twice the dose of ginkgo.
The results of this trial indicated that ginkgo was significantly superior to placebo. (Technically, it was superior in the primary outcome measure, the SKT cognitive test battery, as well as on all secondary outcome measures.) The areas in which ginkgo showed the most marked superiority as compared to placebo included “apathy/indifference, anxiety, irritability/lability, depression/dysphoria and sleep/nighttime behaviour.”
In addition, a 6-month study found ginkgo equally effective as the drug donepezil (taken at a dose of 5 mg daily).
On the other hand, one
fairly large study drew headlines for finding ginkgo extract ineffective.
This 24-week, double-blind, placebo-controlled study of 214 people with either mild to moderate dementia or ordinary age-associated memory loss found no effect with ginkgo extract at a dose of 240 mg or 160 mg daily. However, this study has been sharply criticized for a number of serious flaws in its design.
But in another community-based study among 176 elderly subjects with early-stage dementia, researchers found no beneficial effect for 120 mg of ginkgo extract given daily for six months.
But, a 2011 systematic review of 9 placebo-controlled, randomized trials found more promising evidence for ginkgo.
The trials, which involved 2,372 people with Alzheimer's disease or another form of dementia, ranged from 12-52 weeks. Those in the ginkgo group did have improvements in their cognition scores. And, a subgroup of people with Alzheimer's disease also showed improvements in their activities of daily living.
The ability of ginkgo to prevent or delay a decline in cognitive function is less clear. In a placebo-controlled trial of 118 cognitively-intact adults 85 years or older, ginkgo extract seemed to effectively slow the decline in memory function over 42 months. The researchers also reported a higher incidence of stroke in the group that took ginkgo, a finding that requires more investigation (see
In a 2009 review of 36 randomized trials involving 4,423 patients with declining mental function (including dementia), researchers concluded ginkgo appears safe. But, there is inconsistent evidence regarding whether it works.
Enhancing Mental Function in Healthy People
Ginkgo has shown less consistent promise for
enhancing mental function
in people who experience the relatively slight decline in cognitive function that typically accompanies increased age.
For example, in a double-blind, placebo-controlled trial, 241 seniors complaining of mildly impaired memory were given either placebo or ginkgo for 24 weeks.
The results showed that ginkgo produced modest improvements in certain types of memory.
Another double-blind, placebo-controlled trial examined the effects of ginkgo extract in 40 men and women (ages 55 to 86) who did not suffer from any mental impairment.
Over a 6-week period, the results showed improvements in measurements of mental function.
Possible benefits were seen in six other trials as well, involving a total of about 250 people.
Set against these positive findings is the 24-week study mentioned above, which found no benefit in ordinary age-related memory loss.
The reason for this negative outcome may be flaws in this trial’s design, as noted above.
However, three other studies enrolling a total of about 400 seniors also failed to find significant benefit with daily use of ginkgo.
Another double-blind, placebo-controlled study used a one-time dose of ginkgo, and again found no benefits.
Besides these negative trials, there is another weakness in the evidence: inconsistency even among positive trials. There are numerous measurable aspects of memory and mental function, and studies of ginkgo have examined a great many of these. Unfortunately the exact areas of benefits seen vary widely.
For example, in one positive study, ginkgo may speed the ability to memorize letters but not expand the number of letters that can be retained; while in another positive study, the reverse may be true. This type of inconsistency tends to decrease the confidence one can place in these apparently positive studies, because if ginkgo were really working, one would expect its effects to be more reproducible.
A total of about 15 controlled trials have examined the effects of ginkgo on memory and mental function in younger people.
However, again, results are inconsistent, with many negative results, and the positive ones failing to indicate a consistent pattern of benefit.
Several small double-blind, placebo-controlled studies have evaluated combined treatment with
for enhancing mental function in young people.
The results, overall, are unconvincing. Weak evidence suggests that combining phosphatidylserine with ginkgo might increase its efficacy.
In two studies, ginkgo combined with the
failed to improve mental function.
The bottom line: It is not clear whether ginkgo actually enhances memory and mental function in healthy seniors or healthy younger people. Benefits, if they do exist, are probably slight.
, impaired circulation can cause a severe, cramp-like pain in one's legs after walking only a short distance. According to 9 double-blind, placebo-controlled trials, ginkgo can significantly increase pain-free walking distance.
However, a second review of 11 randomized trials with 477 patients found that although gingko had greater pain-free walking distance than placebo, the improvemed distance was not considered clinically relevant.
One double-blind study enrolled 111 people for 24 weeks.
Subjects were measured for pain-free walking distance by walking up a 12% slope on a treadmill at 3 kilometers per hour (about 2 miles per hour). At the beginning of treatment, both the placebo and ginkgo (120 mg daily) groups were able to walk about 350 feet without pain. By the end of the trial, both groups had improved, although the ginkgo group improved significantly more. Participants taking ginkgo showed about a 40% increase in pain-free walking distance as compared to only a 20% improvement in the placebo group.
Similar improvements were also seen in a double-blind, placebo-controlled trial of 60 people who had achieved maximum benefit from physical therapy.
A 24-week, double-blind, placebo-controlled study of 74 people with intermittent claudication found that ginkgo at a dose of 240 mg per day was more effective than at 120 mg per day.
A 2009 review of 11 trials with 477 subjects suggested that those who took ginkgo biloba were able to walk further than control patients, although the results were limited by differences among the trials.
However, not all studies have been positive. In a randomized trail involving 62 individuals (averaging 70 years of age), 300 mg of ginkgo per day was no better than placebo at improving pain-free walking distance over 4 months of treatment.
One double-blind, placebo-controlled study evaluated the benefits of ginkgo extract for women with
This trial enrolled 143 women, 18 to 45 years of age, and followed them for two menstrual cycles. Each woman received either the ginkgo extract (80 mg twice daily) or placebo beginning on day 16 of the first cycle. Treatment was continued until day 5 of the next cycle, and resumed again on day 16 of that cycle.
As compared to placebo, ginkgo significantly relieved major symptoms of PMS, especially breast pain and emotional disturbance. In another similarly designed trial involving 85 university students,
Ginkgo biloba L.
significantly reduced PMS symptom severity compared to placebo.
In a double-blind, placebo-controlled study of 107 people with various forms of
(specifically, generalized anxiety disorder or adjustment disorder with anxious mood), ginkgo extract taken at a dose of 240 mg or 480 mg daily proved significantly more effective than placebo.
, one of the most common causes of vision loss in seniors, may respond to ginkgo.
In a 6-month, double-blind, placebo-controlled study of 20 people with macular degeneration, use of ginkgo at a dose of 160 mg daily resulted in improved visual acuity.
A 24-week, double-blind study of 99 people with macular degeneration compared ginkgo extract at a dose of 240 mg per day with ginkgo at a dose of 60 mg daily.
The results showed that vision improved in both groups, but to a greater extent with the higher dose.
A 3-month, double-blind trial of 70 people with a variety of
found that ginkgo extract given at a dose of 160 mg twice daily produced results superior to placebo
By the end of the trial, 47% of the people given ginkgo had significantly recovered versus only 18% in the placebo group.
A small double-blind, placebo-controlled trial found that use of ginkgo extract at a dose of 120 mg daily for 8 weeks significantly improved the visual field in people with
extract for treating
have yielded conflicting results.
While some small studies found benefit, the largest and best-designed of these trials failed to find ginkgo effective. In a 12-week, double-blind trial, 1,121 people with tinnitus
were given either placebo or standardized ginkgo at a dose of 50 mg
3 times daily.
The results showed no difference between the treated and the placebo groups.
The standard dosage of ginkgo is 40 mg to 80 mg 3 times daily of a 50:1 extract standardized to contain 24% ginkgo-flavone glycosides. Levels of toxic ginkgolic acid and related alkylphenol constituents should be kept under 5 parts per million.
In an analysis performed in 2006 by the respected testing organization
, some tested ginkgo products were found to be contaminated with lead.
Ginkgo appears to be relatively safe. Extremely high doses have been given to animals for long periods of time without serious consequences, and results from human trials are also generally reassuring.
Safety in young children, pregnant or nursing women, or those with severe liver or kidney disease, however, has not been established.
In all the clinical trials of ginkgo up through 1991 combined, involving a total of almost 10,000 participants, the incidence of side effects produced by ginkgo extract was extremely small. There were 21 cases of gastrointestinal discomfort, and even fewer cases of headaches, dizziness, and allergic skin reactions.
However, there are few potential problems. Perhaps the most serious have been the numerous case reports of internal bleeding associated with use of ginkgo (spontaneous as well as following surgery).
Based on these reports, as well as previous evidence that ginkgo inhibits platelet function,
studies have been performed to determine whether ginkgo significantly affects bleeding time or other measures of blood coagulation, with somewhat inconsistent results.
Prudence suggests that ginkgo should not be used by anyone during the periods before or after surgery or labor and delivery, or by those with bleeding problems such as hemophilia.
It also seems reasonable to hypothesize that ginkgo might interact with blood-thinning drugs, amplifying their effects on coagulation. However, two studies found no interaction between ginkgo and warfarin (Coumadin),
and another found no interaction with clopidogrel. (Although, it did find a slight interaction with the related drug cilostazol.)
While these findings are reassuring, prudence indicates physician supervision before combining ginkgo with blood-thinning drugs.
One study found that when high concentrations of ginkgo were placed in a test tube with hamster sperm and ova, the sperm were less able to penetrate the ova.
However, since we have no idea whether this much ginkgo can actually come into contact with sperm and ova when they are in the body rather than a test tube, these results may not be meaningful in real life.
The ginkgo extracts approved for use in Germany are processed to remove alkylphenols, including ginkgolic acids, which have been found to be toxic.
The same ginkgo extracts are available in the United States. However, other ginkgo extracts and whole ginkgo leaf might contain appreciable levels of these dangerous constituents.
Seizures have also been reported with the use of ginkgo leaf extract in people with previously well-controlled epilepsy; in one case, the seizures were fatal.
It has been suggested that ginkgo might interfere with the effectiveness of some antiseizure medications, specifically
Another possible explanation is contamination of ginkgo leaf products with ginkgo seeds, the seeds of the ginkgo plant contain a neurotoxic substance called 4-methoxypyridoxine (MPN).
Finally, the drug tacrine (also used to improve memory) has been associated with seizures, and ginkgo may affect the brain in ways similar to tacrine.
Regardless of the explanation, prudence suggests that people with
should avoid ginkgo.
According to a study in rats, ginkgo extract may cause the body to metabolize the drug nicardipine (a
calcium channel blocker
) more rapidly, thereby decreasing its effects.
In addition, this finding also suggests potential interactions with numerous other drugs, although more research is needed to know for sure which ones might be affected.
Antibiotics in the
family can cause hearing loss by damaging the nerve carrying hearing sensation from the ear. One animal study evaluated the potential benefits of ginkgo for preventing hearing loss, and found instead that the herb increased damage to the nerve.
Based on this finding, individuals using aminoglycosides should avoid ginkgo.
It has been suggested that ginkgo might cause problems for people with
type 2 diabetes
both by altering blood levels of medications as well as by directly affecting the blood-sugar regulating system of the body.
However, the most recent and best designed studies have failed to find any such actions.
Nonetheless, until this situation is clarified, people with diabetes should use ginkgo only under physician supervision.
Interactions You Should Know About
If you are taking: